NCT06299462 2025-02-25
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
Phase 1/2 Recruiting
Clinical Trials
11 trialsNCT00428688 2023-04-12
Endothelial Function and IMT in Survivors of Hodgkin's Lymphoma
Sheba Medical Center
Completed
NCT02389101 2019-08-05
MILY
Turku University Hospital
Phase NA Completed
NCT01079013 2016-04-20
Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT02507479 2016-04-20
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT00163748 2016-01-08
Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
Bayside Health
Phase 2 Completed
NCT00163761 2016-01-08
Efficacy Study of Outpatient Therapy for Lymphoma
Bayside Health
Phase 2 Completed
NCT01164345 2015-12-03
Mozobil for Autologous Stem Cell Mobilization
Sheba Medical Center
Phase 2 Completed
NCT02145923 2015-06-10
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
Burnasyan Federal Medical Biophysical Center
Phase 1/2 Unknown
NCT01300156 2011-02-21
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)
National Cancer Center, Korea
Phase 2 Unknown
NCT00552825 2007-11-02
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
Sheba Medical Center
Completed